This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Health House International to be Removed from Australian Bourse's Official List MT
Creso Pharma Limited completed the acquisition of Health House International Limited. CI
Health House International Discloses Release of Shares from Escrow MT
Health House International Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Health House International Limited Auditor Raises 'Going Concern' Doubt CI
Health House International CEO to Step Down MT
Health House International Limited Announces Resignation of Paul Mavor as COO, Effective 2 December 2022 CI
Health House International Limited Announces Resignation of David Attwood, CEO, Effective 19 March 2023 CI
COVID-19 Resurgence in China Pushes Down Australian Shares MT
Creso Pharma Signs Deal to Acquire Health House; Creso Shares Fall 9% MT
Health House International Limited Announces Resignation of Henrik Sprengel as Executive Director CI
Sabine Jacker completed the acquisition of THCinol/CBDinol CanPharma GmbH from Health House International Limited. CI
Health House International Selling German Subsidiary for $0.99 MT
Sabine Jacker executed a binding terms sheet to accquire THCinol/CBDinol CanPharma GmbH from Health House International Limited for Ç1. CI
Health House International Limited announced that it has received AUD 0.4 million in funding from Celtic Capital Pty. Ltd. CI
Health House International Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Health House Subsidiary Secures Supply of Cannabis Extract for German Market MT
Creso Pharma Limited signed a non-binding term sheet to acquire Health House International Limited for AUD 5.3 million. CI
Zelira Therapeutics Limited cancelled the acquisition of Health House International Limited. CI
Health House International Posts 8.4% Growth in Fiscal Q2 Cash Receipts MT
Health House International Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Zelira Therapeutics to Acquire Health House International MT
Zelira Therapeutics Limited signed a basic agreement to acquire Health House International Limited for AUD 0.7 million. CI
Health House International's German Subsidiary to Offer Medical Cannabis Training Courses MT
Health House Subsidiary to Supply Cannabis Flowers, Extracts to German Insurance Funds; Shares Rise 3% MT
Chart Health House International
More charts
Health House International Limited is an international distributor specializing in the distribution of medicinal cannabis products across Australasia, United Kingdom and Europe. The Company is a fully licensed and regulated specialized importer, exporter, consolidator and distributor of medicinal cannabis products, distributing medicinal cannabis products to pharmacies, prescribers, specialist medicinal cannabis clinics and researchers across Australasia. It supplies pharmacies, hospital, government departments, veterinarians and other wholesalers with medicinal cannabis and general pharmaceutical products across the United Kingdom and Europe. The Company also integrates education of patients and healthcare professionals in the use of medicinal cannabis as a core part of its activities and is developing digital tools to enable a holistic understanding of usage.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. HHI Stock
  4. News Health House International
  5. Health House International : Completes CanPharma Acquisition, Names CanPharma CFO as New CEO